Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FLUNITY-HD: High-Dose vs Standard-Dose Influenza Vaccine Pooled Analysis
NCT06506812Phase 4Completed
- Start
- May 2025
- Primary completion
- May 2025
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 4 trial of Efluelda in influenza. Started May 2025; status: completed.
02
Drugs
Efluelda
03
Conditions
influenza
Beyond the preview
Go deeper on NCT06506812.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06506812.